Tatry Mountain Resorts a.s. (TMR)
Prague Stock Exchange · Czech Republic · prices in CZK · close of 21 Oct 2026
Key indicators
| Last close | CZK 362.00 |
|---|---|
| 52-week range | 344.00 – 498.00 |
| Return, 1 month / 3 months | −4.7% / +0.6% |
| Return, 1 year / 3 years | −24.3% / −41.6% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 33.3% |
| Worst drawdown (1 year) | -28.2% |
| Average daily value traded | 0.03M CZK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tatry Mountain Resorts is a Slovak company that operates mountain resorts and leisure destinations, chiefly in the High Tatras and other mountain areas of Central Europe. It runs cable cars, chairlifts and ski slopes, along with hotels, restaurants and related visitor services for skiers, hikers and other tourists. The company is based in Slovakia and serves leisure travellers and holidaymakers at its resorts, while also providing services such as mountain transport and accommodation.
The shares are listed on the Prague Stock Exchange in Czech Republic under the code TMR, and the price on this page is in Czech koruna (CZK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tatry Mountain Resorts a.s. (TMR) trades on the Prague Stock Exchange in Czech Republic. It last closed at CZK 362.00 on 21 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 31 of 45 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.3% and over the last three months it rose 0.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Prague Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.2% | ||
| From 52-week high | -27.0% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.6% | ||
| 6-month return | -8.6% | ||
| 12-month return, skipping the last month | -20.5% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.2% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M CZK | ||
| Zero-volume days | 36.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −4.7% |
| 3 months | +0.6% |
| 6 months | −8.6% |
| 1 year | −24.3% |
| 3 years | −41.6% |
| 5 years | −55.6% |
Signals
| 50-day / 200-day average | 370.84 / 390.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.08 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Prague Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.